GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiwanJ Pharmaceuticals Co Ltd (ROCO:6549) » Definitions » Market Cap

TaiwanJ Pharmaceuticals Co (ROCO:6549) Market Cap : NT$722.70 Mil (As of Apr. 03, 2025)


View and export this data going back to 2015. Start your Free Trial

What is TaiwanJ Pharmaceuticals Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). TaiwanJ Pharmaceuticals Co's share price for the quarter that ended in Dec. 2024 was NT$8.12. TaiwanJ Pharmaceuticals Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 80.12 Mil. Therefore, TaiwanJ Pharmaceuticals Co's market cap for the quarter that ended in Dec. 2024 was NT$650.59 Mil.

TaiwanJ Pharmaceuticals Co's quarterly market cap declined from Dec. 2023 (NT$1,089.27 Mil) to Jun. 2024 (NT$901.46 Mil) and declined from Jun. 2024 (NT$901.46 Mil) to Dec. 2024 (NT$650.59 Mil).

TaiwanJ Pharmaceuticals Co's annual market cap increased from Dec. 2022 (NT$796.29 Mil) to Dec. 2023 (NT$1,089.27 Mil) but then declined from Dec. 2023 (NT$1,089.27 Mil) to Dec. 2024 (NT$650.59 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. TaiwanJ Pharmaceuticals Co's Enterprise Value for Today is NT$635.57 Mil.


TaiwanJ Pharmaceuticals Co Market Cap Historical Data

The historical data trend for TaiwanJ Pharmaceuticals Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiwanJ Pharmaceuticals Co Market Cap Chart

TaiwanJ Pharmaceuticals Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 988.06 742.21 796.29 1,089.27 650.59

TaiwanJ Pharmaceuticals Co Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 796.29 1,844.25 1,089.27 901.46 650.59

Competitive Comparison of TaiwanJ Pharmaceuticals Co's Market Cap

For the Biotechnology subindustry, TaiwanJ Pharmaceuticals Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TaiwanJ Pharmaceuticals Co's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TaiwanJ Pharmaceuticals Co's Market Cap distribution charts can be found below:

* The bar in red indicates where TaiwanJ Pharmaceuticals Co's Market Cap falls into.


;
;

TaiwanJ Pharmaceuticals Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

TaiwanJ Pharmaceuticals Co's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )=Share Price (A: Dec. 2024 )*Shares Outstanding (EOP) (A: Dec. 2024 )
=NT$8.12*80.122
=NT$650.59

TaiwanJ Pharmaceuticals Co's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=NT$8.12*80.122
=NT$650.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TaiwanJ Pharmaceuticals Co  (ROCO:6549) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


TaiwanJ Pharmaceuticals Co Market Cap Related Terms

Thank you for viewing the detailed overview of TaiwanJ Pharmaceuticals Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


TaiwanJ Pharmaceuticals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 6-1, Shengyi Road, 3F-4, Section 2, Hsinchu County, Zhubei, TWN, 30261
TaiwanJ Pharmaceuticals Co Ltd is a Taiwan based specialty pharmaceutical company focused on small molecules for unmet medical needs like chronic organ inflammation of metabolic, autoimmune and infectious etiologies. It is also involved in developing novel chemical entities (NCEs) for chronic liver diseases and allergy/asthma.

TaiwanJ Pharmaceuticals Co Headlines

No Headlines